Operator
Operator
Good day, and welcome to this Ultralife Corporation Third Quarter 2015 Earnings Release Conference Call. At this time, for opening remarks and introductions, I'd like to turn the call to Ms. Jody Burfening. Please go ahead.
Ultralife Corporation (ULBI)
Q3 2015 Earnings Call· Thu, Oct 29, 2015
$7.06
-0.77%
Same-Day
-1.02%
1 Week
+9.34%
1 Month
+1.75%
vs S&P
+0.87%
Operator
Operator
Good day, and welcome to this Ultralife Corporation Third Quarter 2015 Earnings Release Conference Call. At this time, for opening remarks and introductions, I'd like to turn the call to Ms. Jody Burfening. Please go ahead.
Jody Burfening
Management
Thank you, Tim and good morning, everyone. This is Jody Burfening of LHA. Thank you for joining us this morning for Ultralife Corporation’s earnings conference call for the third quarter of fiscal 2015. With us on today's call are Mike Popielec, Ultralife’s President and CEO and Phil Fain, Ultralife’s Chief Financial Officer. The earnings press release was issued earlier this morning. And if anyone who has not yet received a copy, I invite you to visit the Company’s Web site, at www.ultralifecorporation.com, where you will find the release under Investor News in the Investor Relations section. Before turning the call over to management, I would like to remind everyone that some statements made during this conference call may contain forward-looking statements based on current expectations. Actual results could differ materially from those projected as a result of various risks and uncertainties. These include potential reductions in U.S. military spending, uncertain global economic conditions and acceptance of the Company’s new products on a global basis. The Company cautions investors not to place undue reliance on forward-looking statements, which reflects the Company’s analysis only as of today’s date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife’s financial results to vary from forward-looking statement as included in Ultralife’s filings with the Securities and Exchange Commission, including the latest Annual Report on Form 10-K. In addition on today’s call, management will refer to certain non-GAAP financial measures that management considers to be useful metrics that differ from GAAP. These non-GAAP measures should be considered as supplemental to corresponding GAAP figures. With those housekeeping matters out of the way, I would now like to turn the call over to Mike. Good morning, Mike.
Mike Popielec
Management
Good morning, Jody and thank you everyone for joining the call this morning. Today, I'll start off by making some overall comments about our third quarter 2015 operating performance, before turning the call over Phil, who will take you through a detailed financial results. After Phil is finished, I'll provide an update on the progress against our revenue initiatives for 2015 then open it up for questions. For Q3 of 2015 we were very pleased to deliver another quarter of total company profitability and positive EPS generating an operating profit of $1.17 million on revenues of $19 million for an operating margin of 6.2%. This represents a year-over-year improvement in operating profit of $1.23 million on a 19% or $3.0 million increase in revenue, again delivering leveraged earnings growth on solid execution of our business model. Revenues at our battery and energy products business increased by 18% over the prior year driven by a 31% increase in government defense sales primarily to the OEM clients and the DLA and a 9% increase in the commercial market led by sales of rechargeable batteries for medical device applications and 9 volt batteries for smoke detectors. For our communication systems business, revenues were up 23% over last year's third quarter driven by sales of our core power amplifiers, universal radio vehicle adapters and power suppliers. Whereas overall communication system shipment volumes are still challenged by transaction timing and DOD budget constraints. The revenue improvements are derived from a broad range of new products being sold through our OEM channels in a more steady day-to-day flow business. With both businesses achieving of meaningful revenue increases in Q3. Total company revenue grew by 19% year-over-year for the third consecutive quarter of solid double-digit increases bringing revenue growth for the first nine months of the year to 23%. Looking at the quality of earnings in Q3, the total company gross margin rate increased year-over-year by 310 basis points to 31% driven again by favorable mix as well as volume leverage. While continuing to fully fund revenue growth initiatives, we also kept a close sign [ph] operating expenses and with the uptick in revenue we're able to reduce operating expenses as a percent of revenue by 350 basis points year-over-year to 24.8%. So in addition to the revenue growth and increase in operating profit, the quality of earnings also continues to improve. And in Q3 of 2015 our operating margin of 6.2% was the highest it has been in almost three years. We know we have much work to do to realize our ultimate goal of being able to deliver consistent and sustainable top and bottom line growth but we are very encouraged to see that our business model assumptions and the heavy lifting done over the last several years are leading us towards that desired steady state. Now I'd like to ask Ultralife's CFO, Phil Fain to take you through the additional details of our third quarter 2015 financial performance. Phil?
Phil Fain
Management
Thank you Mike and good morning everyone. Earlier this morning we released our third quarter results for the period ended September 27, 2015. Consolidated revenues for the third quarter totaled $19 million representing a $3 million or 19% increase from the $16.1 million for the third quarter of 2014. Revenues from our battery and energy product segment were $16.4 million, an increase of $2.5 million or 18% from last year reflecting growth in both government and defense and commercial sales. Government and defense sales grew 31% and was driven by higher sales of batteries and chargers to a large international prime defense suppliers and shipments of primary batteries to the US government’s defense logistics agency for the fourth consecutive quarter. Commercial sales for the third quarter of 2015 increased 9% over 2014 with higher shipments of batteries and chargers into medical channels and 9 volt batteries to large global smoke detector OEMs. As a result of the higher growth for government and defense sales the split between commercial and government and defense sales shifted to 56-44 compared to 61-39 for the 2014 period. Communication systems sales up $2.7 million increased by $0.5 million or 23% over the 2014 period. Similar to the first two quarters we experienced more broad based sales as well as increases in our order flow reflecting increased demand from system integrators and support of US Department of Defense programs and international projects. On a consolidated basis, the commercial to government and defense split was 48-52 versus 53-47 for the year earlier period. Our consolidated gross profit was $5.9 million compared to $4.5 million for the 2014 period. An increase of 32%. As a percentage of total revenues, consolidated gross margin was 31.0% versus 27.9% for last year's third quarter, up 310 basis point increase. The improvements…
Mike Popielec
Management
Thanks Phil. With respect to our revenue growth initiatives in 2015 we have remained focused on three core elements. Expanding our market sales reach, new product development and pursuing acquisitions. Commercial diversification of the battery and energy products business continued in Q3, as sales into commercial markets represented 56% of total B&E revenue. Demand for our products serving the medical market was strong and sales were up 59% versus Q3, 2014 and representing 19% of total B&E sales for the quarter. Within the medical market, after working closely with our strategic business partner over the last two years to develop its end user customers. We're beginning to see a steady demand increase for medical card battery and power systems. Shipments through Q3, 2015 have already exceeded those for all of 2014 are more than 50%. Regarding our 9 volt battery, third quarter 2015 volumes remained solid after a very significant increase demand during the first half of 2015 with 9-volt sales in Q3 representing 21% of total B&E revenue and up 5% year-over-year. And lastly, within our China operation, we continue to gain traction from the locally manufactured lithium final core A [ph] primary batteries largely driven by the use of automobile Topaz applications. In our core battery and energy products government defense market both our international and domestic business development activities remain stable. Several of which involve our upgraded military battery and charger solutions. During the third quarter we've received an additional $1.4 million delivery order from the Defense Logistics Agency or DLA for our 53-90 batteries which will be shipped throughout 2016. And we are actively participating in several other DLA multi-year IDIQ solicitation processes for our legacy and new high capacity hybrid lithium batteries for the soldiers and their specialized tactical communications networks. New product development revenue…
Operator
Operator
[Operator Instructions]. And we'll take our first question from Gary Siperstein with Eliot Rose Asset Management.
Gary Siperstein
Analyst
Hi good morning Mike and Phil. How are you?
Phil Fain
Management
Very good Gary. Thank you.
Gary Siperstein
Analyst
Congratulations on another great quarter sequential and year-over-year growth. And I guess that's four profitable quarters in a row. So that's a milestone as well. And I believe it gets you to close to $0.20 for the trailing 12 months. So is that correct Phil.
Phil Fain
Management
Yeah that's correct yes.
Gary Siperstein
Analyst
I also noticed that sequentially inventory was down a bit and yet with that $8.2 million dialup comp system rewards I suspect you're probably buying some inventory to start shipping that. Mike you had mentioned some nominal shipments in the Q4. Is that correct so? And on the inventory and if it is how much of that inventory is for that $8.3 million contract.
Mike Popielec
Management
Well there is a couple of $100,000 Gary that's related to the $8.2 million contract. Inventory as you know, reduction in inventories are cheapest form of financing. So that's one of our top priorities. And whether its dealing with our core business or dealing with major project wins we're very focused in keeping inventory to the lowest levels possible.
Gary Siperstein
Analyst
And in the quarter Phil you mentioned I believe certain change $1 million EBITDA or cash generation through the three quarters. Was it roughly $2 million in the quarter because it look like cash was just down a $1 million sequentially? And then I'm just trying to quickly do the map on the stock you brought in the quarter you made you probably spend $2 million plus on stock in the quarter or $3 million. So is, does it about $2 million in cash generation.
Phil Fain
Management
Yes you're going to see Gary once you have a change to get into our 10-Q that it's $2.1 million for the quarter 10.8% to sales.
Gary Siperstein
Analyst
Okay super. And back on the batteries out of com systems, the regular batteries we do for the radios. I believe it was April all that it could be up for month or two that three primes $3.2 billion IDIQ and I think it was General Dynamics and Harris and Talus. And am I correct in understanding that we supply the two out of three of those primes?
Mike Popielec
Management
We supply battery products so I think all of three of those primes in various applications and projects Gary.
Gary Siperstein
Analyst
Okay I didn't realized we did do some business with General Dynamics? That was a question so we do sell to General Dynamics?
Mike Popielec
Management
Yeah I mean they're not all equal but we do supply batteries and battery products and chargers to all three of those OEM products. And as I mentioned I think are we try to respect the privacy and confidentiality of each of those three primes because they compete head-to-head.
Gary Siperstein
Analyst
Yeah I understand.
Mike Popielec
Management
We're trying to make sure that we help them win and we work professionally and confidentially with each of those respective parties and their transactions.
Gary Siperstein
Analyst
Absolutely understandable. I guess I'm trying to might get a sense of even though it’s an IDIQ so I know we don't know for sure and when or how long these contracts will last. But if even if our - even if we sell to three but let's say it just represents half of that award and let's say it's awarded in total. Is there any way to figure out what portion of that is the maximum we could get with batteries? I understand some of the radios take 2 batteries some take 4 batteries. So if our customer supply let's say 1.6 billion of the 3.2 regardless of how many years that's over how much is it per radio and then how much is it per X amount of batteries per radio. In other words what's the maximum opportunity there for us is it $25 million is it a $100 million of the $3.2 billion.
Mike Popielec
Management
Gary I think that's very difficult and then almost impossible to try to predict and in fact a lot of the times when we're getting orders from the OEM primes. We don't really have clear visibility if it's indeed for the US contracts that they\ maybe recently announced or for some international contract. What I step back and take a look at it I'm just really pleased to see that all of our customers are starting to receive more big contracts from the U.S. and that's going to have trickle positive down effect to all this.
Gary Siperstein
Analyst
Okay. I noticed that as well so after that 3.2 billion was awarded in April, I think in the subsequent six months there has been several $100 million wins for Harris in the - I don't if it's Rifle Man or Falcon but different things like that and of course Talus has had a couple of wins as well. So that was positively surprising to me that awarding 3.2 billion, there was still maybe another half a billion or billion an additional rewards. Mike on the 8.2 million communication system order, you mentioned some nominal shipments in Q4, can you give us a little more color on that as nominal mean less than million or less than half a million?
Mike Popielec
Management
That is small. Definitely less than a million and really just the type of getting the pump wet if you will, getting some initial units out for some initial testing. But nothing material really in the fourth quarter.
Gary Siperstein
Analyst
Okay. And then you had mentioned I think it was in the news release with that award that most of it will get shipped in the - you mentioned 2016, I thought there was some specificity on the first half of 2016. Is that correct? Could we ship 8 million in the first-half or do you think it will go into Q3?
Mike Popielec
Management
My understanding is that it would go to the first three quarters in next year.
Gary Siperstein
Analyst
Okay. So roughly 2.5 to 3 million a quarter or do you think a little ramp up?
Mike Popielec
Management
Depending on what the needs of the customers are we'll try to ship as quickly as we possibly can. But we know that it's a pretty substantial order for us and we want to make sure that we have our ducks in [ph] roll there is a highest quality and the supply chain is well balanced. So I think it will be three quarters.
Gary Siperstein
Analyst
Okay, super. And Phil on the NOL, so a couple quarters ago you had IRS ruling I think increased your NOL to 80 million. What's the accounting treatment? When do the orders allow you to put that tax asset back on the balance sheet? Now that we have 4 quarters in a row of profitability.
Phil Fain
Management
Sure, to put it in plain English. It's demonstration of sustainable profit over a period of time. My interpretation of that is sustained profitability of at least 2 years. So hopefully at this time next year that is one of the accounting matters that we will be dealing with, putting that on the balance sheet.
Gary Siperstein
Analyst
Okay. Just to check if my math is right. So let's say this time next year we are in this third quarter and order is allow to do the recognize it. So it would everything else being equal, 35% of the 80 million which would equal 28 million divided by roughly 15.5 million shares, so that would be about above the 80 and how does the accounting work, tax asset goes on and then there is a credit net income and then net income frozen to stock holders equity. So would be adding above 80 per share to book, is that correct?
Phil Fain
Management
Gary, that's 100% correct. Very well done.
Gary Siperstein
Analyst
I'm very infrequently 100% right, Phil. So thank you. I think book now stands a little over 4 in a quarter. So forgetting about what earnings you were in the next 12 months, 4 in a quarter and $1.80 so that gets book north of 6. This time next year if you are allowed to recognize it. Is that correct as well?
Phil Fain
Management
Yes.
Gary Siperstein
Analyst
Okay. And then speaking about that 80 million, I know you guys have been looking at the M&A side for a couple of years and with an 80 million NOL, Mike, doesn't it make sense since the same amount of work is typically involved in kicking the tires and doing your diligence on a $30 to $40 million business as a kind of $20 million business and later of the size of the NOL doesn't it make sense to maybe buy something a little bigger and a little more profitability and a little higher quality. So you have a significant enough margin of error, in other words if you bought something that's only throwing off a $1 million in profitability that would get shielded by the NOL and something goes wrong because M&A difficult and sometimes it's surprises post-closing. Let's say a $1 million you think it's going to contribute and then it contribute zero, wouldn't they make sense to buy something that maybe is cash 2 or 3 million in profitability and then if we’re million off you still have 1 or 2 million in profitability. So then it could be much more materially accretive. Is that how you guys are thinking of things and looking at things?
Phil Fain
Management
I would love to be able to design an acquisition that would be delightful. When we look at, if I think your logic is exactly correct and at the same time you are looking at actual companies and trying to find out to manage versus liabilities of the companies you potentially could buy. Sometimes you have a really large company that has a significant amount of heavy lifting in integration and consolidation to do. So as the ton of work and realizing the benefits there other times you can have a small company that maybe as just plug and go and continue to drive organic growth. So I think you get the full spectrum. I think you logic is correct and how are you articulated. We have to look at each individual acquisitions on its own merits. And you never get a 100% of what you want, but if we can get add 80% 90% and it can make a strategic addition to our company meaning that post-acquisition and integration and consolidation as a case maybe we continue to grow at a faster rate organically. Obviously there is some pros and cons to the different size of acquisitions. So I think your logic is correct. I don't disagree with you at all, but we're trying to put that to the filter of the actual candidates that we're looking at it.
Gary Siperstein
Analyst
Okay. That's fair. And at medical you mentioned that the fibrillate opportunity separate from medical cards. Is that something that the FDA is looking at now and you're waiting your partner is waiting for an approval. And is it something that's more of a assuming to get approval by June 30 that's more of a back half opportunity. Can you give anymore color on that?
Phil Fain
Management
Yeah it would look at them as 2016 opportunities, I mean there is a couple of different AB [ph] manufacturers that we're working with. So it's not just one. But yeah I would say it’s can fair to think but really a sort of a back half of 2016 type opportunity.
Gary Siperstein
Analyst
Okay. And in previous conference calls, I think there was an opportunity both on metering and tolls so I think tolls, for tolls roads or something like that in China. Is there any update in that area?
Phil Fain
Management
No those continue to go well. I mean as you may recall our China strategy is really three pronged. We have manufacturing of our 9 volt battery, a world class 9 volt product and having it really close proximity to the OEM device makers who want to have their supply chain little very close where they build their product for shipping globally. So we exploit that opportunity there in China. We use that sort of benefit of having the capacity and manufacturing capability there and the cost associated with being able to serve that supply chain by going into the in country activity and in country demand for electric metering and toll pass. That business has been stable or we're continuing to get some nice volumes there. But because the overall China market is a little bit slower and a lot of heavy manufacturers are in China watching that really closely, but we don't see any significant negative material impact on the revenue stream, but those applications are still very much in part of our day-to-day. And then third piece that just the completeness is taking both our 9 volt product in our locally manufactured China products and solve those on a global scale which have the full support of our brand, our quality and technology parameters such as we can use it as a launch point to grow our business on a global scale. So of those three really just one third of that is in in-country business of which it's primarily focused on toll pass and electric metering type applications.
Gary Siperstein
Analyst
Superb okay. And Phil I think with the pickup on the government military side on the batteries. We for the first time I think moved into this year and in spite of building up some a typically some backlog. Can you tell you if the backlog has remained the same from June 30 to September 30 or is it increased or decreased?
Phil Fain
Management
It's approximately the same Gary.
Gary Siperstein
Analyst
Okay. And then Phil again on I think we've talked earlier about EBITDA or cash flow being roughly $7 million change through the 9 months. So you usually have a little improvement in the fourth quarter versus the third quarter seasonally. I know we've discussed this now before and it just seems to repeat itself. So if I assume a slight improvement in business in Q4 due to the seasonality that would get us close if everything else being equal and apples-versus-apples. It sounds like cash flow could go from $7.5 million to $10 million if we add in the fourth quarter. And $10 million is I guess $0.67 per share on 15 million shares outstanding. Does that sound that right?
Phil Fain
Management
Let me make a correction the 7.4 million of EBITDA is on a trailing 12 month basis.
Gary Siperstein
Analyst
Okay, that's trailing 12. Okay.
Phil Fain
Management
This seasonality goes. In today's world with the ordering from the government and defense sector, I really discount any seasonality. If you depend on seasonality you are generally depending on hope and we are more focused on the orders and the opportunities at hand.
Gary Siperstein
Analyst
Okay. I agree with that, but does it happen always - not always, but I thought the last couple of years Q4 was better than Q3. So even though we want to work on orders on hand hasn't attended to be a little better than Q3?
Phil Fain
Management
Last year was, however I can give you 10 different reasons why that was and I don't want to one-offs, because it really isn't such a thing as one-off. But there is multiple opportunities that we are always looking at. Some occur, some go forward rarely do we lose an opportunity. The timing a week difference in shipping or booking or receiving based on the shipping terms does make a difference. So I look at it the backlog in the orders and opportunities that we're currently dealing well.
Gary Siperstein
Analyst
Okay. So I know you guys don't make give guidance or make earnings projections. But I just want to walk through a scenario, just tell me if my thinking is right, if my assumptions are correct and if they come true. So with $0.14 through nine months and let’s say conservatively Q4 is the same as Q3, that gets us to $0.21 for the year and let's say next year organically we grow our earnings just a penny or two or quarter that gets to $0.26 that's only maybe $0.02 a quarter 300 grand with the NOL that's $0.02. So you sort it can say if we could get $0.02 in organic growth that's another $0.08. So $0.22 and $0.08 get roughly to $0.30 and then if you ship the majority of the $8.2 million contract. First of all should that contract we look it at the normal corporate margin of 30%?
Phil Fain
Management
I prefer not to comment on that. We generally don't disclose the term of a major project award. We simply disclose the sum of all business that is done.
Gary Siperstein
Analyst
Okay. Well, for my calculation if I assume 30% and again I know you are not commenting and let's say 7.5 million of that ships next calendar year at 30% that's 2.1 million over 15 million shares that's another $0.15 a share protected by the NOL and I was at roughly $0.30 just with the little slight organic growth, so that gets need a $0.45 without an additional comp systems award and without the possibility of accredited acquisition. I'm not asking you to agree or disagree with that as guidance. But if I'm correct is there any holes in my logic on that?
Phil Fain
Management
Gary, as usual your math is very good and I'm not going to comment. I don't want to go out and give any quantitative guidance at this time. But I think as we all know there is always ups and downs and complexities and all sorts of different things that do occur. But if you purely look at it based on a linear quantitative equation I can't argue with anything that you just said. But again it's something we are not going to comment on at this time.
Gary Siperstein
Analyst
Okay, all right. So just a damn. So just I can hear myself. Thanks. So if I have nominal organic growth plus the 8.2 million contract that you have in hand if that gets me to $0.40 to $0.45 and if in the next 15 months you win just one more com systems order and/or an accretive acquisition and/or organic growth with all your initiatives and medical and tolls and metering et cetera and/or the military increase continues to pace and/or accelerate. If I am correct and I know you're not commenting on that if everything goes well and I'm not trying to nail you down on the quarter but for the calendar year. If that gets me the $0.40 to $0.45 or $0.45 to $0.50 and going from $0.22 this year to $0.45 next year let's say we got to be at happy EPS growth rate that's a 25 being and because commercials coming on strong $0.40 to $0.45 in times of 25. So you could logically make it case for $12 to $15 stock if all it be above came through. Therefore it seems that we're pretty cheap here in the fixed dollar range especially in light of the fact that we're also going to get that and I did include the - that's the one time on the realization of the tax assets those are just operating earnings. But that gets the book up to 6. So basically if I'm right we're a company that year from now could be value today at book value and with the 22, 25 PE selling it double digits. So again with all that in light and all that potential without really reaching for anything above and beyond. Tell me why you guys on now that you got four quarters under your belt, how can you not being more aggressive on the IR front?
Phil Fain
Management
I'm happy to comment on that Gary. First of all, we have seen a pretty significant increase and investor increase and we have certainly taken those calls and responded to those calls. And I would say that the interest in the company has certainly gone up. So that's certainly one arm of the IR strategy and that arm is what we call saido. That is the most important part of the IR strategy. As I'm sure you're very much aware a number of companies go out there. They make a lot of promises without much to show for it. Our strategy has been one of focusing virtually all of our time an internal operations to put in place a business model that's highly leveraged and then execute upon that so that we can build very clearly a sound track record that we call our saido ratio. So at this time, we taken the additional calls and we're certainly looking at its tending our IR program as we go forward and that's not to mean that we're going to go out in front of large groups of people and present and way the pumps and all that. It's really all about meeting with investors more on a one-on-one basis answering the questions with our focus always being on saido first and using that as the most valuable plank in our IR strategy.
Gary Siperstein
Analyst
Okay I heard you Phil on two things, first saido is not a form of karate right. It's not s-a-I-d-o deal, it's what you say you're going to do than you do it right.
Phil Fain
Management
Absolutely correct.
Gary Siperstein
Analyst
Okay for those who never goes saido before? And then secondly I hear you and I'm certainly are not asking you to take your eye of the book from an operational point of view. But we are a public company and IR is the part of the responsibility of the public company and we want to get the appropriate valuation for what you've accomplished. So I know every boards different every management is different. But now that you have full quarters into your belt presumably with the good fourth quarter we'll have a year plus under our belt. And as I just highlights things look pretty interesting for next year which is half of the potential bogies come and do. So all I'm saying is there are companies out there earning less than you there are companies not profitable that do some form of investor relations just to make a broader audience so where at the story. So I don't think it's going to kill anyone if you guys attempt one or two or three conferences in a calendar year period looking for sale side coverage and/or instead of waiting for people to come to New York where you go to Chicago or LA or Miami you need some pie-side small value people. Some sort of I do not want to get my - but you certainly have enough evidence of what you are doing and I don’t think three over proactive outgoing IR efforts is going to take your eye off the ball and then obviously you deal easily with reactive ones when people call you and chose to show off at your corporate headquarters. I just want to say that for the record.
Phil Fain
Management
We certainly understand your point of view and Mike and I can assure that we are discussing this topic internally along with most effective approach and timing. Certainly we understand all the dynamics of being a public company we have a lot of experience in this arena and we are using the experience that we have had in the past to go forward with the most valuable with the most optimal value proposition we can to existing and perspective shareholders and I do appreciate your thoughts on it certainly understand your point of view.
Gary Siperstein
Analyst
All right, guys. Thanks very much and congratulations on again on the great progress.
Phil Fain
Management
Thank you, Gary.
Operator
Operator
[Operator Instructions] There appear to be no other question at this time I will turn it back over to Mike for any closing remarks.
Mike Popielec
Management
Great, well thank you once again everyone for joining us today for our Q3 2015 results earnings call. I look forward to sharing with you our quarterly progress on each quarter’s calls in the future. Thank you very much and have a great day.
Operator
Operator
And that does conclude today’s conference. We appreciate your participation.